Stockreport

Merck Secures EU Nod for RSV Antibody Enflonsia in Infants [Yahoo! Finance]

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF respiratory tract disease in newborns and infants during their first RSV season. Enflonsia is contraindicated for infants with hypersensitivity to the active substance [Read more]